One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

Over 6% of American adults are suffering from long COVID, survey finds 05:10. Two new clinical trials to test potential treatments for long COVID are now set to launch, the National Institutes of ...

The phase 2 investigational new drug clinical trial tested whether a 15-day course of Paxlovid, an FDA-approved antiviral for acute COVID-19, could also help long COVID patients.

The drugs were identified by an earlier SILC-funded study that, over the past 18 months, examined over 5,400 blood proteins from 1,028 participants with and without long COVID found 13 common ...

The drug may be most effective in the early days of illness. Participants who took metformin within four days of their COVID-19 symptoms starting had a 60% lower chance of long COVID, while those ...

For the people who can’t get rid of COVID or suffer from symptoms that linger months or even a year after getting infected, a South Florida drug trial could provide hope. The drug, called ler… ...

In the two years since she caught the coronavirus, 38-year-old Jessica McGovern has cycled through “well over 100 drugs, supplements, and therapies” to try to keep her long-COVID symptoms at ...

A drug that has shown promise in HIV patients could be successful in combating symptoms for coronavirus "long haulers.” The trial is set to start this spring and doctors say if it works, it ...

For example, current long COVID clinical trials are testing 5 to 15 days of antivirals like Paxlovid. But treatment of persistent hepatitis C virus requires 8 to 12 weeks of antiviral therapy.